Friday, May 11, 2007

NeuroVista Raises $33.8M In Series B

Seattle-based NeuroVista announced this week that it has closed a Series B financing worth $33.8M. The funding for the firm came from Advanced Technology Ventures and Delphi Ventures, along with existing investors Three Arch Partners, Sprout Group, and Foundation Medical Partners. NeuroVista is developing treatments for patients with epilepsy. More information »